Market Overview:
The global livestock external medicine market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth is attributed to the increasing demand for meat and milk products, rising awareness about animal health, and the increasing incidence of zoonotic diseases. The global livestock external medicine market can be segmented on the basis of type, application, and region. On the basis of type, the market can be divided into external use and internal use. External use dominates the global livestock external medicine market owing to its easy availability and low cost as compared to internal use products. On the basis of application, cattle accounts for a major share in terms of revenue in 2017 owing to their high population across regions such as North America, Latin America Europe Asia Pacific ,and Middle East & Africa .
Product Definition:
Livestock external medicine is the branch of veterinary medicine that deals with the diagnosis and treatment of diseases and injuries affecting animals other than humans. It includes the study and use of medicines, vaccines, surgical techniques, and other therapies used to prevent or cure such conditions. The importance of livestock external medicine lies in its ability to maintain the health and well-being of livestock populations, which are essential for food production and economic stability.
External Use:
External use is the part of alternative medicine that is used by individuals or veterinary practitioners to treat livestock outside the normal medical practice. External uses for animals are mostly based on traditional methods and modern techniques. The main factor that propels growth in external use of animals is increasing awareness among people, government support, and demand for animal health products.
Internal Use:
Internal use and it's usage in livestock external medicine market refers to the internal use of antibiotics for non-medical purposes. The main objective is to increase productivity by reducing mortality rates, improve feed efficiency, and enhance meat quality & quantity. Antibiotics are used as growth promoters in animals raised for food production; they are also used as additives or premixes with vaccines or other medicines to treat infections caused by bacteria, viruses, fungi or parasites.
Application Insights:
Based on the application, the global livestock external medicine market is segmented into cattle, equine, swine and poultry. The cattle segment held the largest share in 2017 due to extensive usage of vaccines for calves against diseases such as paratyphoid fever, respiratory infections and coronavirus. Moreover, increasing demand for dairy products is expected to boost product use in future.
The swine segment is anticipated to witness lucrative growth over forecast period due to rising prevalence of diseases such as tuberculosis among pigs across the globe. According to a study published by Tuberculosis Research Foundation International in 2016; around 60-80% of all pigs get infected with TB at some point during their lifetime. Vaccination programs against this disease are implemented globally along with awareness campaigns so that pig owners can take necessary steps for its prevention among animals.
Regional Analysis:
North America dominated the global livestock external medicine market in 2017. The region is expected to witness a considerable growth rate of 5.4% over the forecast period, owing to high animal health awareness and rising prevalence of infectious diseases in animals. In addition, increasing demand for meat products is anticipated to drive regional market growth during the same period.
The Asia Pacific region accounted for a revenue share of 23.2% in 2017 owing to high animal health concerns coupled with growing disposable income levels among consumers and farmers alike as this region has largest number of cattle population worldwide; China & India account for approximately 34%of world’s cattle respectively).
Growth Factors:
- Increasing demand for meat and dairy products from the developing countries is expected to drive the livestock external medicine market growth.
- Rising awareness about animal health and hygiene among the farmers is anticipated to propel the market growth during the forecast period.
- Growing number of zoonotic diseases is projected to create lucrative opportunities for livestock external medicine manufacturers in near future.
- Proliferation of private veterinary clinics and hospitals is likely to boost demand for livestock external medicines over next few years. 5) Technological advancements in veterinary diagnostics are estimated to fuel adoption of novel therapeutics, which in turn will spur growth of Livestock External Medicine market during forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Livestock External Medicine Market Research Report
By Type
External Use, Internal Use
By Application
Cattle, Equine, Swine, Poultry
By Companies
Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Livestock External Medicine Market Report Segments:
The global Livestock External Medicine market is segmented on the basis of:
Types
External Use, Internal Use
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cattle, Equine, Swine, Poultry
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim
- Zoetis
- Merck
- Elanco
- Bayer
- Virbac
- Ceva Sante Animale
- Vetoquinol
- Bimeda Animal Health
- Chanelle
Highlights of The Livestock External Medicine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- External Use
- Internal Use
- By Application:
- Cattle
- Equine
- Swine
- Poultry
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Livestock External Medicine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Livestock external medicine is the use of medications and other treatments on livestock.
Some of the major companies in the livestock external medicine market are Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle.
The livestock external medicine market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Livestock External Medicine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Livestock External Medicine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Livestock External Medicine Market - Supply Chain
4.5. Global Livestock External Medicine Market Forecast
4.5.1. Livestock External Medicine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Livestock External Medicine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Livestock External Medicine Market Absolute $ Opportunity
5. Global Livestock External Medicine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Livestock External Medicine Market Size and Volume Forecast by Type
5.3.1. External Use
5.3.2. Internal Use
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Livestock External Medicine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Livestock External Medicine Market Size and Volume Forecast by Application
6.3.1. Cattle
6.3.2. Equine
6.3.3. Swine
6.3.4. Poultry
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Livestock External Medicine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Livestock External Medicine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Livestock External Medicine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Livestock External Medicine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Livestock External Medicine Demand Share Forecast, 2019-2026
9. North America Livestock External Medicine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Livestock External Medicine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Livestock External Medicine Market Size and Volume Forecast by Application
9.4.1. Cattle
9.4.2. Equine
9.4.3. Swine
9.4.4. Poultry
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Livestock External Medicine Market Size and Volume Forecast by Type
9.7.1. External Use
9.7.2. Internal Use
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Livestock External Medicine Demand Share Forecast, 2019-2026
10. Latin America Livestock External Medicine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Livestock External Medicine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Livestock External Medicine Market Size and Volume Forecast by Application
10.4.1. Cattle
10.4.2. Equine
10.4.3. Swine
10.4.4. Poultry
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Livestock External Medicine Market Size and Volume Forecast by Type
10.7.1. External Use
10.7.2. Internal Use
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Livestock External Medicine Demand Share Forecast, 2019-2026
11. Europe Livestock External Medicine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Livestock External Medicine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Livestock External Medicine Market Size and Volume Forecast by Application
11.4.1. Cattle
11.4.2. Equine
11.4.3. Swine
11.4.4. Poultry
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Livestock External Medicine Market Size and Volume Forecast by Type
11.7.1. External Use
11.7.2. Internal Use
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Livestock External Medicine Demand Share, 2019-2026
12. Asia Pacific Livestock External Medicine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Livestock External Medicine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Livestock External Medicine Market Size and Volume Forecast by Application
12.4.1. Cattle
12.4.2. Equine
12.4.3. Swine
12.4.4. Poultry
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Livestock External Medicine Market Size and Volume Forecast by Type
12.7.1. External Use
12.7.2. Internal Use
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Livestock External Medicine Demand Share, 2019-2026
13. Middle East & Africa Livestock External Medicine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Livestock External Medicine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Livestock External Medicine Market Size and Volume Forecast by Application
13.4.1. Cattle
13.4.2. Equine
13.4.3. Swine
13.4.4. Poultry
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Livestock External Medicine Market Size and Volume Forecast by Type
13.7.1. External Use
13.7.2. Internal Use
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Livestock External Medicine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Livestock External Medicine Market: Market Share Analysis
14.2. Livestock External Medicine Distributors and Customers
14.3. Livestock External Medicine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Boehringer Ingelheim
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Zoetis
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Elanco
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bayer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Virbac
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ceva Sante Animale
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Vetoquinol
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Bimeda Animal Health
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Chanelle
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook